New Hampshire HB 172: relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.

Status: Committee Report: Inexpedient to Legislate HB172 11/08/2023 (Vote 19-0; CC) (as of 2023-11-16)

State: New Hampshire · Session: 2023 · Bill: HB 172

Sponsors: Jess C. Edwards, Peter R. Leishman

View New Hampshire HB 172 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.